<unk><unk>  (RDN) is a minimally invasive, endovascular catheter-based procedure invented to treat patients with severe resistant hypertension. Preliminary data suggest that<unk><unk>  is safe and results in a sustained blood pressure reduction of approximately 30 mm Hg at a three-year follow up. However, in light of the negative results from SYMPLICITY HTN–3, the beneficial effect of<unk><unk>  remains uncertain.
Renal sympathetic denervation
Urinary diversion
Osmotic diuresis
Rebound diuresis
Third spacing of fluids
Renal artery stenosis angioplasty and stenting
Diuresis
Bladder augmentation